Skip to main content
Premium Trial:

Request an Annual Quote

InterVenn Biosciences: Tillman Pearce, Klaus Lindpaintner

Tillman Pearce has been appointed as chief medical officer of InterVenn Biosciences. He replaces Klaus Lindpaintner, who held the role of chief medical and chief scientific officer and has become distinguished scientist, a new role at the firm. Pearce joins InterVenn from OBI Pharmaceuticals, where he was chief medical officer. He holds an MD from Medical College of Georgia.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.